Origins and molecular effects of hypoxia in cancer
Seminars in Cancer Biology · 2024-11 · 106-107 · 166-178
DOI: 10.1016/j.semcancer.2024.10.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024-11. Verfasst von Sergio Rey-Keim und 1 weiteren Autor:innen. Beteiligte Einrichtung: UCD School of Medicine, University College Dublin, Belfield, Dublin D04 C7X2, Ireland; UCD Conway Institute of Biomolecular and Biomedical Research, …. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 207 Literaturangaben.
Abstract (Originalsprache)
Hypoxia (insufficient O2) is a pivotal factor in cancer progression, triggering genetic, transcriptional, translational and epigenetic adaptations associated to therapy resistance, metastasis and patient mortality. In this review, we outline the microenvironmental origins and molecular mechanisms responsible for hypoxic cancer cell adaptations in situ and in vitro, whilst outlining current approaches to stratify, quantify and therapeutically target hypoxia in the context of precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCD School of Medicine, University College Dublin, Belfield, Dublin D04 C7X2, Ireland; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin D04 C7X2, Ireland. Electro…
Zitieren
APA
Rey-Keim, S., & Schito, L. (2024). Origins and molecular effects of hypoxia in cancer. Seminars in Cancer Biology, 106-107, 166-178. https://doi.org/10.1016/j.semcancer.2024.10.001
Vancouver
Rey-Keim S, Schito L. Origins and molecular effects of hypoxia in cancer. Seminars in Cancer Biology. 2024;106-107:166-178. doi:10.1016/j.semcancer.2024.10.001
BibTeX
@article{ReyKeim2024,
author = {Rey-Keim, Sergio and Schito, Luana},
title = {Origins and molecular effects of hypoxia in cancer},
journal = {Seminars in Cancer Biology},
year = {2024},
volume = {106-107},
pages = {166--178},
doi = {10.1016/j.semcancer.2024.10.001}
}
EUVIMED